drug prices

The U.S. Supreme Court on Monday declined to hear a pharmaceutical industry challenge to the Medicare drug price negotiation program created under former President Joe Biden's Inflation Reduction Act, according to Reuters. The justices rejected appeals from drugmakers including Novo Nordisk (NYSE:...

Sen. Peter Welch (D-Vt.) said Wednesday he would support President Donald Trump's "most favored nation" drug pricing proposal, marking a rare moment of bipartisan alignment on prescription drug costs. Speaking at the Axios Future of Health summit, Welch said he would "not only vote for it," but...

Eli Lilly and Co. (NYSE:LLY) revealed plans to inject an extra $4.5 billion into two of its Indiana manufacturing sites on Wednesday. This move escalates its total capital expansion in the state since 2020 to over $21 billion. The additional funding is intended to support the production of...

Mark Cuban, billionaire entrepreneur and CEO of Costplusdrugs.com, praised TrumpRx, a prescription drug platform launched by President Donald Trump, for its efforts in reducing the cost of certain medications for patients. Cuban took to X on Wednesday to talk about the positive impact of the drug...

The cost of drug discovery has always been time. Nvidia Corp (NASDAQ:NVDA) says it just crushed that cost by 70% — and Eli Lilly And Co (NYSE:LLY) just put $1 billion behind the claim. At JPMorgan's healthcare conference, Nvidia wasn't pitching AI as a helper in the lab. It was pitching AI as a...

On Sunday, President Donald Trump vowed to slash prescription drug prices through a sweeping executive order. What Happened: Trump took to Truth Social and announced plans to sign a new executive order. Under what he called a "most favored nation" pricing policy, the President said the executive...

Robert F. Kennedy Jr., President Donald Trump's pick for health secretary, addressed a wide range of medical-related topics on Wednesday during a confirmation hearing with the Senate Finance Committee. While Kennedy’s tone in each back-and-forth varied, depending on the senator, it was...

CVS Health Inc’s (NYSE:CVS) subsidiary, Aetna Inc., has filed a lawsuit against more than 20 generic drug manufacturers. The lawsuit alleges a coordinated scheme to fix prices, allocate markets, and stifle competition. The result was a significant overcharge for essential medications....

On Wednesday, the U.S. Department of Health and Human Services (HHS), working via the Centers for Medicare & Medicaid Services (CMS), released final guidance for the second cycle of the Medicare Drug Price Negotiation Program. This initiative aims to provide lower drug prices starting in 2026...

The Biden administration has disclosed the prices for the first ten prescription drugs that have been negotiated between Medicare and drug manufacturers. This significant step is part of an effort to make expensive medications more affordable for older Americans. What Happened: The announcement,...

President Donald Trump signed an executive order Sunday that aims to lower prescription drug prices in the United States for certain drugs by linking them to those paid by other developed countries. What Happened: The executive order mandates that for Medicare Part B and Part D prescription...

Health and Human Services Secretary Alex Azar and the Food and Drug Administration announced Wednesday that the Trump administration has dropped a long-standing resistance to importing drugs and outlined a plan that could eventually allow the importation of some cheaper prescription drugs from...

The Trump administration will no longer proceed with a large-scale overhaul of the drug-rebate industry. What Happened Pharmacy benefit managers (PBMs) negotiate a drug discount on behalf of health insurers and collect a commission for themselves as profit. Critics of the system argued it gives...

A U.S. federal judge ruled against a proposal that pharmaceutical companies need to disclose wholesale prices for their products in T.V. advertising, Reuters reported. What Happened The U.S. Department of Health and Human Services Secretary Alex Azar disclosed a new rule in early May which would...

The upward trajectory of prescription drug prices in the U.S. has drawn the ire of lawmakers. Prices of drugs are staggeringly high in the U.S. when compared to other developed countries such as Japan and in Europe. House lawmakers are discussing a plan that could work to curb high...